share_log

HC Wainwright & Co. Maintains Buy on Tempest Therapeutics, Raises Price Target to $47

HC Wainwright & Co. Maintains Buy on Tempest Therapeutics, Raises Price Target to $47

HC Wainwright & Co.维持对Tempest Therapeutics的买入,将目标价上调至47美元
Benzinga ·  2023/10/11 09:52

HC Wainwright & Co. analyst Joseph Pantginis maintains Tempest Therapeutics (NASDAQ:TPST) with a Buy and raises the price target from $35 to $47.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯维持Tempest Therapeutics(纳斯达克股票代码:TPST)的买入,并将目标股价从35美元上调至47美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发